Metropolitan Life Insurance Company (MetLife)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-2,729
| Closed | -$20.7K | – | 2448 |
|
2022
Q1 | $20.7K | Sell |
2,729
-4,137
| -60% | -$31.4K | ﹤0.01% | 2077 |
|
2021
Q4 | $70.1K | Sell |
6,866
-1,576
| -19% | -$16.1K | ﹤0.01% | 2637 |
|
2021
Q3 | $113K | Sell |
8,442
-2,645
| -24% | -$35.5K | ﹤0.01% | 2462 |
|
2021
Q2 | $243K | Hold |
11,087
| – | – | ﹤0.01% | 2007 |
|
2021
Q1 | $267K | Hold |
11,087
| – | – | ﹤0.01% | 1817 |
|
2020
Q4 | $199K | Hold |
11,087
| – | – | ﹤0.01% | 1937 |
|
2020
Q3 | $128K | Hold |
11,087
| – | – | ﹤0.01% | 2079 |
|
2020
Q2 | $269K | Hold |
11,087
| – | – | ﹤0.01% | 1617 |
|
2020
Q1 | $122K | Hold |
11,087
| – | – | ﹤0.01% | 1903 |
|
2019
Q4 | $293K | Sell |
11,087
-513
| -4% | -$13.6K | ﹤0.01% | 1651 |
|
2019
Q3 | $264K | Buy |
11,600
+3,935
| +51% | +$89.6K | ﹤0.01% | 1684 |
|
2019
Q2 | $235K | Hold |
7,665
| – | – | ﹤0.01% | 1793 |
|
2019
Q1 | $127K | Hold |
7,665
| – | – | ﹤0.01% | 2179 |
|
2018
Q4 | $147K | Buy |
7,665
+847
| +12% | +$16.2K | ﹤0.01% | 2020 |
|
2018
Q3 | $357K | Hold |
6,818
| – | – | 0.01% | 1610 |
|
2018
Q2 | $296K | Buy |
6,818
+2,224
| +48% | +$96.7K | ﹤0.01% | 1675 |
|
2018
Q1 | $170K | Buy |
+4,594
| New | +$170K | ﹤0.01% | 1992 |
|